This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
The phase for this study is not defined.
Show me locations

The purpose

This trial aims to determine which treatment modality is better for treatment of the convergence insufficiency subtype of intermittent exotropia.

Provided treatments

  • Procedure: Post exercise Surgery
  • Procedure: Orthoptics
  • Procedure: Postop orthoptics
  • Procedure: Post exercises surgery

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01435876. The sponsor of the trial is Sudhalkar Eye Hospital and it is looking for 76 volunteers for the current phase.
Official trial title:
Treatment for Convergence Insufficiency Intermittent Exotropia; A Randomized Trial